Ibrutinib

Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK).

Ibrutinib was developed by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma.

单词	Ibrutinib
释义	Ibrutinib 英语百科 Ibrutinib Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK). Ibrutinib was developed by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma.
随便看	display means display means using special optical effect display mechanism platform display medium display member Display memory display memory module display menu display method display microprocessor Display mode DISPLAYMODE Display model Display modes display module Display monitor display monitor central monitoring system Display,mRNA Differential display multiplex data bus display multiplexing display name display networks display of a single character display of bearing display of commodities in the store windows